USFDA Hit For Ranbaxy
  • Elizabeth George
  • Sep 16 2013

September 16: The USFDA has issued an import alert against Ranbaxy and says that it will not be able to import drugs produced at its Mohali unit. While the order does not have a significant financial impact on the company, it has dampened sentiment as the unit was being primed for new launches. Bloomberg TV India discusses how this ban raises doubts about the launch of some of the company’s key exclusive drugs.